GeneDx (WGS) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free WGS Stock Alerts $19.61 -0.78 (-3.83%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 12:12 PM | marketbeat.comDecheng Capital LLC Buys Shares of 103,604 GeneDx Holdings Corp. (NASDAQ:WGS)Decheng Capital LLC acquired a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 103,604 shares of the company's stock, valued at apMay 30 at 5:48 AM | americanbankingnews.comCasdin Capital, Llc Purchases 7,500 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockMay 30 at 1:36 AM | americanbankingnews.comGeneDx (NASDAQ:WGS) Shares Gap Up After Insider Buying ActivityMay 29 at 1:07 PM | msn.comOver $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are BuyingMay 29 at 10:22 AM | marketbeat.comGeneDx (NASDAQ:WGS) Shares Gap Up on Insider Buying ActivityGeneDx (NASDAQ:WGS) Shares Gap Up After Insider Buying ActivityMay 29 at 5:17 AM | insidertrades.comInsider Buying: GeneDx Holdings Corp. (NASDAQ:WGS) Director Purchases 7,500 Shares of StockMay 29 at 4:48 AM | americanbankingnews.comGeneDx Holdings Corp. (NASDAQ:WGS) Director Casdin Capital, Llc Acquires 18,304 Shares of StockMay 28, 2024 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Director Casdin Capital, Llc Acquires 7,500 SharesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) Director Casdin Capital, Llc acquired 7,500 shares of the firm's stock in a transaction on Thursday, May 23rd. The shares were bought at an average cost of $19.59 per share, for a total transaction of $146,925.00. Following the completion of the acquisition, the director now directly owns 2,761,009 shares of the company's stock, valued at approximately $54,088,166.31. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.May 22, 2024 | globenewswire.comGeneDx to Participate in Upcoming Investor ConferencesMay 20, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Gap Down to $22.39GeneDx (NASDAQ:WGS) Shares Gap Down to $22.39May 16, 2024 | insidertrades.comCasdin Capital, Llc Acquires 50,000 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockMay 14, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Down 3% GeneDx (NASDAQ:WGS) Shares Down 3%May 13, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Sets New 1-Year High at $22.75GeneDx (NASDAQ:WGS) Sets New 52-Week High at $22.75May 2, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Trading Down 7.2%GeneDx (NASDAQ:WGS) Shares Down 7.2%May 2, 2024 | finance.yahoo.comGeneDx Holdings Corp. (NASDAQ:WGS) Just Reported First-Quarter Earnings And Analysts Are Lifting Their EstimatesMay 1, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Sets New 52-Week High Following Analyst UpgradeGeneDx (NASDAQ:WGS) Sets New 12-Month High After Analyst UpgradeMay 1, 2024 | insidertrades.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Kevin Feeley Sells 1,104 SharesApril 30, 2024 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $12,188.16 in StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 1,104 shares of the company's stock in a transaction on Monday, April 29th. The shares were sold at an average price of $11.04, for a total transaction of $12,188.16. Following the completion of the transaction, the chief financial officer now owns 30,836 shares of the company's stock, valued at approximately $340,429.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.April 30, 2024 | finanznachrichten.deGeneDx Holdings Corp.: GeneDx Reports First Quarter 2024 Financial Results and Business HighlightsApril 30, 2024 | marketbeat.comTD Cowen Increases GeneDx (NASDAQ:WGS) Price Target to $24.00TD Cowen boosted their target price on GeneDx from $14.00 to $24.00 and gave the stock a "buy" rating in a report on Tuesday.April 30, 2024 | markets.businessinsider.comGeneDx is about to announce its earnings — here's what to expectApril 30, 2024 | finance.yahoo.comGeneDx Holdings Corp (WGS) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues and ...April 29, 2024 | msn.comWGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024April 29, 2024 | msn.comGeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 GuidanceApril 29, 2024 | finance.yahoo.comGeneDx Holdings Corp (WGS) Q1 2024 Earnings: Surpasses Revenue Expectations and Narrows LossesApril 29, 2024 | msn.comGeneDx reports Q1 resultsApril 29, 2024 | globenewswire.comGeneDx Reports First Quarter 2024 Financial Results and Business HighlightsApril 28, 2024 | msn.comGeneDx Q1 2024 Earnings PreviewApril 27, 2024 | finance.yahoo.comGeneDx Holdings Corp. (WGS)April 23, 2024 | finance.yahoo.comGeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease DatasetApril 23, 2024 | globenewswire.comGeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease DatasetApril 22, 2024 | marketbeat.comBTIG Research Increases GeneDx (NASDAQ:WGS) Price Target to $15.00BTIG Research raised their target price on shares of GeneDx from $11.00 to $15.00 and gave the company a "buy" rating in a research note on Monday.April 15, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) PT Raised to $11.00The Goldman Sachs Group boosted their price objective on GeneDx from $6.00 to $11.00 and gave the stock a "neutral" rating in a report on Monday.April 4, 2024 | globenewswire.comGeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024March 20, 2024 | insidertrades.comGeneDx Holdings Corp. (NASDAQ:WGS) Insider Kareem Saad Sells 2,008 SharesMarch 19, 2024 | marketbeat.comKareem Saad Sells 2,008 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) insider Kareem Saad sold 2,008 shares of the firm's stock in a transaction on Monday, March 18th. The stock was sold at an average price of $10.59, for a total transaction of $21,264.72. Following the transaction, the insider now directly owns 29,517 shares of the company's stock, valued at approximately $312,585.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 16, 2024 | finance.yahoo.comWGS Apr 2024 7.500 callMarch 16, 2024 | finance.yahoo.comWGS Apr 2024 7.500 putMarch 16, 2024 | insidertrades.comGeneDx Holdings Corp. (NASDAQ:WGS) Director Casdin Capital, Llc Purchases 40,000 SharesMarch 14, 2024 | globenewswire.comGeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of GenomicsMarch 13, 2024 | edition.cnn.comGeneDx Holdings Corp. Class AMarch 1, 2024 | marketbeat.comOracle Investment Management Inc. Boosts Position in GeneDx Holdings Corp. (NASDAQ:WGS)Oracle Investment Management Inc. lifted its stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 14.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 994,580 shares of the company's stock after purchasing an additionalFebruary 26, 2024 | globenewswire.comGeneDx to Participate in 44th Annual Cowen Health Care ConferenceFebruary 25, 2024 | finance.yahoo.comWGS Mar 2024 7.500 putFebruary 23, 2024 | finance.yahoo.comWGS Mar 2024 10.000 putFebruary 23, 2024 | benzinga.comGeneDx Hldgs Stock (NASDAQ:WGS) Insider TradesFebruary 21, 2024 | finanznachrichten.deGeneDx Holdings Corp.: GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024February 21, 2024 | benzinga.comGeneDx Hldgs Stock (NASDAQ:WGS), Guidance and ForecastFebruary 21, 2024 | finance.yahoo.comGeneDx Holdings Corp. (NASDAQ:WGS) Q4 2023 Earnings Call TranscriptFebruary 21, 2024 | markets.businessinsider.comHere's what Wall Street expects from GeneDx's earnings Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. WGS Media Mentions By Week WGS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WGS News Sentiment▼1.250.81▲Average Medical News Sentiment WGS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WGS Articles This Week▼111▲WGS Articles Average Week Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PRVA News Today USPH News Today PNTG News Today INNV News Today TALK News Today DCGO News Today SHCR News Today PIII News Today EUDA News Today ATPC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WGS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyOn June 10, Nvidia makes its next big moveWeiss RatingsUnlock Explosive Gains with This Defense StockBehind the MarketsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe Worst is Yet to Come…Porter & CompanyDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
